Abstract:We aims to assess the evidence of nasal continuous positive airway pressure (nCPAP) for treating stroke patients with sleep-disordered breathing (SDB). We conducted a systematic review encompassing both published randomized controlled trials that compared the use of nCPAP versus no treatment or sham CPAP. Two reviewers independently assessed eligibility, extracted characteristics and results, evaluated risk of bias, and synthesized findings using meta-analysis. Four studies (comprising five publications, with a total of 274 participants) met the inclusion criteria. The included studies exhibited a high risk of bias in at least one assessed domain, particularly regarding blinding of participants or personnel and other sources of bias. The impact of nCPAP on all-cause mortality and new stroke occurrence was inconclusive and statistically nonsignificant. However, a pooled analysis revealed an overall favorable effect of nCPAP on vascular mortality (odds ratio (OR) 0.16, 95% CI 0.03 to 0.93; P=0.04; n=196; 2 studies (3 reports); I2=0%). However, the analysis of adverse events, independence in activities of daily living (ADL), depression, and quality of life was hindered by insufficient data. Consequently, our review underscores the limited conclusion of nCPAP's efficacy in treating SDB post-stroke and underscores the need for further investigation.

Nasal continuous positive airway pressure for sleep-disordered breathing after stroke: a systematic review